Defibrillation testing and early neurologic outcome

International Heart Journal

Volumn 49, Issue 5, 2008, Pages 553-563

  Karaoǧuz, Remzi ^a,b   Altln, Timuein ^a   Atbaşoǧlu, E Cem ^a   Işikay, Canan ^a   Güraslan, Bahar ^a   Akyürek, Ömer ^a   Beton, Osman ^a   Vurgun, Kutay ^a   Yüceman, Nezih ^a   Soylu, Kazim ^a   Güldal, Muharrem ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Cognitive function; Implantable cardioverter defibrillator; Neuron specific enolase; Neuronal injury

Indexed keywords

NEURON SPECIFIC ENOLASE; ENOLASE;

ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; CLINICAL ARTICLE; COGNITION; DEFIBRILLATION; ENZYME BLOOD LEVEL; FEMALE; HEART VENTRICLE FIBRILLATION; HUMAN; MALE; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; OPERATION DURATION; OUTCOME ASSESSMENT; PATIENT SAFETY; POSTOPERATIVE CARE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; TREATMENT RESPONSE; BLOOD; CARDIOVERSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEFIBRILLATOR; ENZYMOLOGY; EQUIPMENT; FOLLOW UP; MIDDLE AGED; NERVOUS SYSTEM; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; TREATMENT OUTCOME;

AGED; COGNITION; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; EQUIPMENT SAFETY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NERVOUS SYSTEM; NEUROLOGIC EXAMINATION; PHOSPHOPYRUVATE HYDRATASE; TREATMENT OUTCOME; VENTRICULAR FIBRILLATION;

EID: 58149184575     PISSN: 13492365     EISSN: 13493299     Source Type: Journal    
DOI: 10.1536/ihj.49.553     Document Type: Article

References (23)

1. Gregoratos G, Abram J, Epstein AE, et al. ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Calimittee to Update the 1998 Pacemaker Guidelines). J Am Coll Cardiol 2002; 40. 1703-9.
2. Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005; 352: 225-37.
3. Sasaki S, Niwano S, Fukaya K et al. Clinical usefulness of electrophysiologic study (EPS)-guided risk stratification for life-threatening arrhythmia in patients with heart failure. Int Heart J 2007; 48: 155-63.
4. Hayes DL. Implantation techniques. In: Hayes DL, Lloyd MA, Friedman PA, eds. Cardiac Pacing and Defibrillation: A Clinical Approach. Armonk, NY. Futura Publishing, 2000: 159-200.
5. Russo AM, Sauer W, Gerstenfeld EP, et al. Defibrillation threshold testing: is it really necessary at the time of implantable cardioverter-defibrillator insertion? Heart Rhythm 2005; 2: 456-61.
6. Swerdlow CD, Russo AM, Degroot PJ. The dilemma of ICD implant testing. Pacing Clin Electrophysiol 2007; 30: 675-700. (Review)
7. Singer I, Edmonds H Jr. Changes in cerebral perfusion during third-generation implantable cardioverter defibrillator testing. Am Heart J 1994; 127: 1052-7.
8. de Vries JW, Bakker PF, Vissa GH, Diephuis JC, van Huffelen AC. Changes in cerebral oxygen uptake and cerebral electrical activity during defibrillation threshold testing. Anesth Analg 1998; 87: 16-20.
9. Adams DC, Heyer EJ, Emerson RG, et al. Implantable cardioverter-defibrillator. Evaluation of clinical neurologic outcome and electroencephalographic changes during implantation. J Thorac Cardiovasc Surg 1995; 109: 565-73.
10. Murkin JM, Baird DL, Martzke JS, Yee R. Cognitive dysfunction after ventricular fibrillation during implantable cardioverter/defibrillator procedures is related to duration of the reperfusion interval. Anesth Analg 1997; 84: 1186-92.
11. Gold MR, Breiter D, Leman R, Rashba EJ, Shorofsky SR, Hahn SJ. Safety of a single successful conversion of ventricular fibrillation before the implantation of cardioverter defibrillators. Pacing Clin Electrophyiol 2003; 26: 483-6.
12. Strickberger SA, Klein GJ. Is defibrillation testing required for defibrillator implantation? J Am Coll Cardiol 2004; 44: 88-91. (Review)
13. Pires LA, Johnson KM. Intraoperative testing of the implantable cardioverter-defibrillator: how much is enough? J Cardiovasc Electrophysiol 2006; 17: 140-5.
14. Dworschak M, Franz M, Czerny m, et al. Release of neuron-specific enolase and S 100 after implantation of cardioverters/defibrillators. Crit Care Med 2003; 31: 2085-9.
15. Weigl M, Moritz A, Steinlechner B, et al. Neuronal injury after repeated brief cardiac arrests during internal cardioverter defibrillator implantation is associated with deterioration of cognitive function. Anesth Analg 2006; 103: 403-9.
16. Wunderlich MT, Ebert AD, Kratz T, Goertler M, Jost S, Herrmann M. Early neurobehavioral outcome after stroke is related to release of neurobiochemical markers of brain damage. Stroke 1999; 30: 1190-5.
17. Rosén K Sunnerhagen KS, Herlitz J, Blomstrand C, Rosengren L. Serum levels of the brain-derived proteins S-100 and NSE predict long-term outcome after cardiac arrest. Resuscitation 2001; 49: 183-91.
18. Rech TH, Vieira SR, Nagel F. Brauner JS, Scalco R. Serum neuron-specific enolase as eady predictor of outcome after in-hospital cardiac arrest: a cohort study. Crit Care 2006; 10: R 133.
19. Herrmann M, Ebert AD, Galazky I, Wunderlich MT, Kunz WS, Huth C. Neurobehavioral outcome prediction after cardiac surgery: role of neurobiochemical markers of damage to neuronal and glial brain tissue. Stroke 2000; 31: 645-50.
20. Wechsler D. Wechsler Memory Scale-Revised. New York, NY: The Psychological Corporation; 1987.
21. Golden CS. Stroop Color and Word Test: A Manual for Clinical and Experimental Uses. Chicago, IL: Stoelting Co.,; 1978.
22. Wechsler D. Wechsler Adult Intelligence Scale-Revised: Manual. San Antonio, TX: The Psychologic Corporation; 1981.
23. van Dijk D, Keizer AM, Diephuis JC, Durand C, Vos LJ. Hijman R. Neurocognitive dysfunction after coronary artery bypass surgery: a systematic review. J Thorac Cardiovasc Surg 2000; 120: 632-9.